Blue Horseshoe Stocks: Options Ideas & More


American Green, Inc. ERBB

We’ve seen a great performance out of ERBB over the past few sessions, since including it in Thursday morning’s premarket report. That morning the company had announced that it had purchased the entire town of Nipton California (>>View PR) with grand plans to turn it into a cannabis tourism destination.

Since then, ERBB has seen a big move on the chart, trading up from Thursday’s low of .0012 to a new 52-week high of .0046 yesterday, marking a three-day swing of 283% on the highest volume we’ve seen out of the stock since last fall.

We’re interested to keep an eye out for updates on the Nipton project, which will apparently consist of several facets including production of CBD-infused water sourced from local aquifers. ERBB is a stock we’ve followed for years, but we’ll want to pay extra attention in the weeks and months ahead to stay on top of that story and see how it affects the stock.


Options Ideas

Valeant Pharmaceuticals International, Inc. VRX – Despite a Q2 loss and guidance reduction posted in its report, VRX, which had been on a downtrend for several sessions prior, surged in premarket trading this morning.  We’re going to want to try to take advantage of the volatility created here with a set of options to track for potential swing trades. .

We’re going to be watching the VRX Weekly $16-17.50 Calls which could see some big activity following a potential early dip from profit-taking followed by a rip to new highs.

______

Michael Kors Holdings, Ltd. KORS – On the flip-side, KORS is a stock that was experiencing a pretty good uptrend for an extended period leading up to its own earnings report, in which the company easily exceeded Wall Street’s expectations, and raised guidance.

Like the previously mentioned play, we’ll look for the classic dip-and-rip formation, and will be tracking the KORS Weekly $41.50-43.50 Calls as we head into this midweek.


Extended Watchlist:
ENDP, CLRB, XNET, VH, CHFS, DRRX

Incoming search terms:

  • august 2017 stocks

Blue Horseshoe Stocks: USRM, ICLD Follow-ups & More

U.S. Stem Cell, Inc. USRM
We’ve been tracking USRM very closely over the past few weeks, since initially mentioning it on the morning of February 27th and witnessing a huge subsequent increase( .014-.0545,+289%). We monitored the consolidation off of that high down to .0175, and once again signaled that it was time to give it our close attention last week on the 15th.

The rebound that has since occurred has been very nice, with USRM surging back to .053 yesterday, a jump of 203% over its .0175 swing low. So that’s twice now, in the span of less than a month that we’ve seen a 200% move out of this play. We’re obviously going to continue following it, with the type of price action and volatility we’ve seen so far, USRM is currently a swing-trader’s paradise.


InterCloud Systems, Inc. ICLD

We also had a ringer with ICLD earlier this month, when we signaled it on the 2nd before the stock took off from a low of .0157 to a high .0985, a 527% rip. After watching it consolidate off of those highs for a few days, re brought it back to readers’ attention in yesterday’s premarket report, and our attempted timing of the reversal couldn’t have worked any better.

From an early low of .0302, the stock steadily made its way up to a high .0439 shortly after 1PM, for an intraday spike of 45% and held more than half of its daily gains into the close, so this one will also remain on our watchlist in coming sessions.


Northern Dynasty Minerals, Ltd. NAK

We tagged NAK last Thursday after watching the stock search out a bottom for quite awhile. The stock did bounce, and has thus far posted a 31% increase, reaching 1.58 yesterday and closing just a tick below at 1.57, as you can see on the included snapshot.

Also on the chart, we can see that the RSI is on the verge of cracking the 50-line, and the MACD has just crossed in a bullish manner. Conditions seem to be ripe for the possibility of a continued rebound, so we’ll pay close attention to NAK in sessions to come.


Extended Watchlist:
IDOI, NSPR, FCEL, HTBX, ESPR, CLRB

Blue Horseshoe Stocks: FL, CNXS Recaps & More

Franchise Holding International, Inc. FNHI

On Friday morning, we were giving our readers an update on the stellar performance of FNHI since we’d first called it back on the 8th. subsequent to which time, the stock was trading at a low of .0061.

Not only did FNHI follow it up with a solid intraday pop, but also extended our total observed range in just over three weeks by a significant margin.

Friday, FNHI traded from 0265-.0449 for an intraday push of 69% That new high, measured from our witnessed low, comes out to an overall upswing of 636%

The stock also closed with strength at .0421, holding most of its daily advance, so we’ll be watching it this morning as we prepare to kick off a new trading week.


Connexus Corp. CNXS

Speaking of big movers, our tag of CNXS in Friday’s report came just in the nick of time for us to catch a fantastic intraday performance.

The stock traded up from a low of .0051, cracked through the penny barrier, and reached as high as .0159, for a whopping run of 212% on the day!

That performance marked the third straight session of higher highs and higher lows, so we’re definitely going to be on the lookout for a possible continuation of that trend. Ideally, we’d like to see CNXS hold support at or above Thursday’s swing high of .0092 on any pullbacks.


Foot Locker, Inc. FL - Options Update

We also need to bring readers up to speed on the excellent  post-earnings options idea we formulated on Friday for Foot Locker, the FL 03/17 $70-75 Calls.

Those contracts provided daytraders with some cherry opportunities for quick gains with FL’s bullish intraday run from 70.37 to 75.37. The potential profits were as follows:

$70 Calls – Range: 2.00-5.00 – Max Gain: 150%
$72.50 Calls – Range: .95-3.60 – Max Gain: 279%
$75 Calls – Range: .26-2.00 – Max Gain: 669%


Special Note on Bitcoin

Prior to last week, the all time high for Bitcoin was $1160, last week that high was broken, and has been making higher highs since.

Winklevoss Bitcoin Trust ETF (Pending:COIN) is subject to approval. Essentially, if the SEC raises no issues by the end of the comment period, the ETF can move forward unhindered. It has caused an increased interest in the space, and as a result, we’ve got our eyes on stocks like the above-mentioned CNXS, along with others like BTSC and GAHC


Extended Watchlist:
CLRB, CEMP, USRM, ABHI, AMFE, IBRC

Blue Horseshoe Stocks: MYHI Recap & Other Updates

Mountain High Acquisitions Corp. MYHI

Our first order of business this morning is to review the recent activity in MYHI, another cannabis stock amid the huge selection we’re constantly tracking. We’ve been all over this play in the month of January, beginning with the first report of the calendar year, and appearing routinely since then, all while maintaining a general uptrend.

Our witnessed low came in the session immediately following that first premarket report of 2017 back on January 3rd, at .09. Over the course of this month, MYHI has streaked skyward with some very impressive multi-day surges, the latest of which led to a new high yesterday.

We also included MYHI in yesterday’s premarket report, so for those readers who haven’t been with us long enough to have witnessed the full story on this play, single-session gains of a significant magnitude were also available. MYHI ran from a low of .5616 to its new high of .90 on heavy volume, an intraday push of 63%

The high mark represented an overall upswing of 900% from our observed low on the 3rd, exactly three weeks ago, so huge cheers are in order for anyone who has been along for this fantastic ride!


Other Pot Stock Updates

Speaking of the marijuana space, which has definitely been a prime area of focus for us in recent months especially, we had a couple of our other running cannabis interests that were included in yesterday’s premarket report end up performing well on the day.

We had Rocky Mountain High Brands, Inc. RMHB trade up from .13 to .16 for a modest 23% intraday push, reaching overall gains of 74% from the .092 low we observed after including the stock in Friday’s report.

There was also Hemp, Inc. HEMP, which was another one we put in the first report of the year and have been tracking ever since. It spiked 16% intraday yesterday from .0467 to .054, and from our witnessed low of .03, a total rise of 80%


Cellectar Biosciences, Inc. CLRB

CLRB is hitting our scanner in the premarket today, gapping up to the tune of 15% and showing all the symptoms of a solid bottom-bouncer.

There is a gap on the chart between approximately 1.80 and 2.20. We would like to see the stock maintain support above the 50DMA(1.50) and potentially make a run to fill that gap.


VanEck Vectors Gold Miners ETF (GDX) – Options Reminder

Just a quick reminder on our options ideas from yesterday’s report; the GDX 02/10 $24-25.50 Calls which we put on extended watch, made some decent progress on the first day, producing gains ranging between 20-40%

We’ll continue to track these ideas for the possibility of further increases for as long as gold itself can maintain its overall uptrend. In this case, that would likely mean holding support above the $1200/oz mark.


Extended Watchlist
PURA, MYDX, UAMM, PKTX, ISBG, ICNB, MIHI(News)

Incoming search terms:

  • Bulo myhi

Blue Horseshoe Stocks: Pharma News Watchlist & More

Pharma News Watchlist:

We’ve got a trio of pharma plays to add to our watchlist on the heels of fresh news releases for each of them this morning. Each stock is gapping up significantly in the premarket, and we’ll be waiting in the wings once the session commences to see if we can use the resulting activity to our advantage.

Akebia Therapeutics, Inc. AKBA – Per the newly announced agreement out today, AKBA has entered into a Collaboration and License Agreement to carry forward with the development of one of its treatments. The deal comes with an immediate payment of $125M, a cash infusion that represents roughly 40% of the company’s total market cap as of yesterday.

______

ACADIA Pharmaceuticals, Inc. ACAD – In the case of ACAD, we’ve gotten word of positive top-line results in a Phase II study it was conducting on the company’s Alzheimer’s drug.  To leverage the present activity to our advantage here, we’re going to track the ACAD Weekly $28-31 Calls. (>>View PR)

_______

Conatus Pharmaceuticals, Inc. CNAT

Here we have another collaboration and licensing deal, for CNAT’s liver drug, which is going to be bringing a $50M cash infusion Conatus’ way. That’s just the initial tranche, with more payments to follow as outlined in the relevant filing (>>View 8-K)


Globalstar, Inc. GSAT

We put GSAT on watch as a possible momentum play in yesterday morning’s premarket report, and while it didn’t break out in a major way, it did continue the trend of solid upward momentum that has been observed in recent sessions. From an early low of 1.25, the stock ran as high as 1.60; a 28% pop.

The performance, while not astronomical, was certainly enough to hold our interest in continuing to monitor GSAT’s activity moving forward.


Cellectar Biosciences, Inc. CLRB – Reminder

We just wanted to take a quick moment to reiterate a possible bottom-play selection we made last week in the form of CLRB. We’re still tracking this one, and think it has a good chance to produce a recovery, possibly following the holiday break. So we’re going to want to leave a space on our watch screens reserved for CLRB in the days and weeks ahead.


Extended Watchlist:
AXPW, CAPS, MFST, ENDV, ETRM, EXAD